Pratt Collard Advisory Partners’s AbbVie ABBV Stock Holding History

Pratt Collard Advisory Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$496K	Sell	4,402 -3,057	-41%	-$344K	0.33%	65
2021 Q1	$807K	Sell	7,459 -19	-0.3%	-$2.03K	0.58%	50
2020 Q4	$801K	Buy	7,478 +84	+1%	+$8.07K	0.58%	49
2020 Q3	$648K	Hold	7,394	–	–	0.53%	53
2020 Q2	$726K	Hold	7,394	–	–	0.65%	50
2020 Q1	$563K	Sell	7,394 -125	-2%	-$10.6K	0.57%	56
2019 Q4	$666K	Sell	7,519 -166	-2%	-$13.8K	0.51%	56
2019 Q3	$582K	Sell	7,685 -114	-1%	-$7.82K	0.46%	58
2019 Q2	$567K	Sell	7,799 -209	-3%	-$16.4K	0.45%	60
2019 Q1	$645K	Sell	8,008 -140	-2%	-$11.5K	0.52%	55
2018 Q4	$751K	Hold	8,148	–	–	0.68%	43
2018 Q3	$771K	Sell	8,148 -250	-3%	-$23.7K	0.62%	54
2018 Q2	$778K	Sell	8,398 -99	-1%	-$9.67K	0.67%	51
2018 Q1	$804K	Sell	8,497 -303	-3%	-$33.3K	0.7%	46
2017 Q4	$851K	Buy	+8,800	New	+$829K	0.7%	49

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Pratt Collard Advisory Partners's ABBV Position: Q2 2021 in Review

Pratt Collard Advisory Partners reduced its AbbVie (ABBV) stake by 41% in Q2 2021, selling an estimated $344K and leaving 4,402 shares worth $496K. The position accounts for 0.33% of the portfolio, ranked #65.

Pratt Collard Advisory Partners first reported a position in ABBV in Q4 2017 and has held it in 15 quarters since. The position peaked at $851K in Q4 2017. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Pratt Collard Advisory Partners held 4,402 shares of AbbVie worth $496K as of Q2 2021.
Pratt Collard Advisory Partners sold 3,057 AbbVie shares in Q2 2021, an estimated $344K.
AbbVie made up 0.33% of Pratt Collard Advisory Partners's portfolio in Q2 2021, its #65 holding.
Pratt Collard Advisory Partners first reported a position in AbbVie in Q4 2017 and has held it in 15 quarters since.
Pratt Collard Advisory Partners's AbbVie position peaked at $851K in Q4 2017.
2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.